2020: a game changer year for AMR? (Video)
At the AMR Congress 2020, Dame Sally Davies, UK AMR Special Envoy asked Thomas Cueni, IFPMA’s Director General, if industry has done enough to tackle AMR and what remains to be done to create a sustainable market and long-term R&D investment into antibiotics.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit ifpma.org.Learn more
Media ContactElliot Dunster email@example.com